Myocardium at risk and infarct size after thrombolytic therapy for acute myocardial infarction: implications for the design of randomized trials of acute intervention.

MLA

Gibbons, R. J., et al. “Myocardium at Risk and Infarct Size after Thrombolytic Therapy for Acute Myocardial Infarction: Implications for the Design of Randomized Trials of Acute Intervention.” Journal of the American College of Cardiology, vol. 24, no. 3, Sept. 1994, pp. 616–23. EBSCOhost, https://doi.org/10.1016/0735-1097(94)90005-1.

APA

Gibbons, R. J., Christian, T. F., Hopfenspirger, M., Hodge, D. O., & Bailey, K. R. (1994). Myocardium at risk and infarct size after thrombolytic therapy for acute myocardial infarction: implications for the design of randomized trials of acute intervention. Journal of the American College of Cardiology, 24(3), 616–623. https://doi.org/10.1016/0735-1097(94)90005-1

Chicago

Gibbons, R J, T F Christian, M Hopfenspirger, D O Hodge, and K R Bailey. 1994. “Myocardium at Risk and Infarct Size after Thrombolytic Therapy for Acute Myocardial Infarction: Implications for the Design of Randomized Trials of Acute Intervention.” Journal of the American College of Cardiology 24 (3): 616–23. doi:10.1016/0735-1097(94)90005-1.